TNR logo
Global Roofing Materials Market is Expected to Grow at a CAGR of 4.7% over the Forecast Period (2024 – 2034): A Report by The Niche Research
July 25, 2024 09:23 ET | The Niche Research
Wilmington, Delaware, July 25, 2024 (GLOBE NEWSWIRE) -- Roofing materials are products used to cover and protect the top of buildings from weather elements such as rain, sunlight, wind, and snow....
TNR logo
Unlock limitless Innovation: Accelerate your Business with the Future-Ready No-code AI Platform Market Revolution: TNR, The Niche Research
July 25, 2024 09:00 ET | The Niche Research
Wilmington, Delaware, July 25, 2024 (GLOBE NEWSWIRE) -- No-code AI platform market is experiencing robust growth, driven by increasing demand for accessible AI solutions across industries. These...
TNR logo
Unlocking New Horizons in Health: TNR, The Niche Research Reveals the Transformative Power of Minor Cannabinoids
July 25, 2024 09:00 ET | The Niche Research
Wilmington, Delaware, July 25, 2024 (GLOBE NEWSWIRE) -- Minor cannabinoids refer to the lesser-known compounds found in the cannabis plant, distinct from the well-known THC (tetrahydrocannabinol)...
TNR logo
Unlocking Security: TNR, The Niche Research Report Illuminates the Global Wireless Security Camera Market's Bright Future
July 25, 2024 09:00 ET | The Niche Research
Wilmington, Delaware, July 25, 2024 (GLOBE NEWSWIRE) -- The global wireless security camera market continues to expand robustly, driven by increasing concerns over security and surveillance across...
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
July 25, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
windtree_logos_CMYK_Side1-e1524153991167.png
Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data
July 25, 2024 08:00 ET | Windtree Therapeutics
WARRINGTON, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage...
checkpoint.jpg
Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma
July 25, 2024 07:30 ET | Checkpoint Therapeutics, Inc
WALTHAM, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that the...
Altisource-Logo-Big-tag-RGB_300dpi.jpg
Altisource Announces Second Quarter 2024 Financial Results
July 25, 2024 07:04 ET | Altisource Portfolio Solutions S.A.
LUXEMBOURG, July 25, 2024 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage...
Barrick logo RGB.jpg
Porgera Remains On Track Despite Mulitaka Landslide Challenges
July 25, 2024 07:00 ET | Barrick Gold Corporation
All amounts in US dollars PORT MORESBY, Papua New Guinea, July 25, 2024 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) – Despite the operational challenges presented by the...
ConnectOne_Logo.jpg
ConnectOne Bancorp, Inc. Reports Second Quarter 2024 Results; Declares Common and Preferred Dividends
July 25, 2024 07:00 ET | ConnectOne Bancorp, Inc.
ENGLEWOOD CLIFFS, N.J., July 25, 2024 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net...